A Predictive Value of Red Blood Cell Distribution Width in Hodgkin Lymphoma in Iraqi Patients
DOI:
https://doi.org/10.36330/kmj.v21.i1.18970Keywords:
Hematology, RDW, Hodgkin lymphomaAbstract
Aim: to assess role of Red Blood cell Distribution Width as predictive factor in Hodgkin lymphoma. Patient, material, methods: the study to assess Iraqi patient including male and female with Hodgkin lymphoma age between (16-55 years) by compare RDW level at time of diagnosis then after 2 cycle and lastly at the end of chemotherapy. We enrolled in this study for period from Dec.2021 to Dec.2022 in Baghdad medical city. All patient included was send for full laboratory evaluation before beginning and during follow up. Result: The mean age of the patients was 30.49±11.24 years (range 16-55 years). Males were more common than females (56% vs. 44%). The most common disease stage was IIB stage accounting for 42%, followed by IVB stage (36%) and IIIB stage (24%). B-symptoms present in 82% of the patients, while bulky disease (>10cm) was reported in 18% of them .The mean RDW-SD in patients with complete response at diagnosis and after two cycles therapy was 48.02±9.66 fl and 51.17±9.8 fl, respectively which was much higher than that of patients with progressive disease/partial response (28.83±10.23 fl and 43.03±11.37 fl, respectively) with significant differences. Furthermore, patients with complete response demonstrated higher mean value of RDW-CV and RDW-SD at the end of treatment (17.66±3.5% and 52.0±6.6 fl, respectively) than those with progressive disease/partial response (14.67±2.45% and 36.87±12.71 fl), with highly significant differences. Conclusion: High RDW CV and SD showed no significant association with high disease activity. Higher RDW showed significant association with anemia and low albumin. patients with complete response demonstrated higher mean value of RDW-CV and RDW-SD at the end of treatment than those with progressive disease/partial response with highly significant differences. RDW showed no significant correlation of these parameters neither with age nor with the disease stage.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Alaa Kadhum, Adel S. Aqabi

This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the KMJ website, given that KMJ is responsible to appreciate citation for their work, which is released under CC-BY-4.0 enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.









